dennis mccain
  • Home
  • Investing
    • Dividend Kings
    • Div Aristocrats
    • Div Champions
    • Business Dev Cos
    • Monthly Dividends
  • Options
    • Weekly Options

Best Ideas This Week

These companies are estimated to have a very nice one year total return on investment.

Home

Best Ideas 30 July 2017

7/30/2017

0 Comments

 
Picture
Here's a couple of stock ideas I'm looking at for next week. These are companies I'll consider investing in with any funds that become available in my accounts. They're each showing a nice estimated 1yr ROI, increasing earnings, and pay at least a minimal dividend. I believe each of these has a greater potential return than analysts currently expect. As with all of my investments, I'll start with a small positions and then add to that position over time through dividend reinvestment, the sale of stock options and direct purchases on the open market.
Picture
ImmunoGen, Inc., a clinical-stage biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugate (ADC) technology. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha for the treatment of platinum-resistant ovarian cancer; IMGN529, an ADC that is in Phase 1b/2 clinical trials for B-cell malignancies; coltuximab ravtansine, which is in Phase 2 trials for B-cell malignancies; IMGN779 that is in Phase 1 clinical trials for the treatment of acute myeloid leukemia (AML); and IMGN632, a preclinical CD123-targeting ADC for the treatment of hematological malignancies, including AML. ImmunoGen, Inc. has collaborations with Roche; Bayer HealthCare AG; Sanofi; Biotest AG; Novartis Institutes for BioMedical Research, Inc.; Eli Lilly and Company; Amgen; Takeda Pharmaceutical Company Limited; Merck; and CytomX Therapeutics, Inc. ImmunoGen, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.
(Summary) (Company) (Chart)
30 July 2017
Price $6.96
1yr Target $7.67
Analysts 5
Dividend $0.00
Payout Ratio 0.00%

1yr Cap Gain 10.20%
Yield 0.00%
1yr Tot Return 10.20%

P/E ---
PEG ---
Beta 2.41
EPS (ttm) $-1.63
EPS next yr $-1.49
Forward P/E ---
EPS next 5yr ---
1yr Price Support ---

Market Cap $648.25 Mil
Revenues $57.40 Mil
Earnings $-142.20 Mil
Profit Margin ---

Quick Ratio 3.40
Current Ratio 3.50
Debt/Equity ---
1yr RevGR 117.24%
3yr RevGR 36.16%
5yr RevGR -2.47%

1yr EarnGR ---
3yr EarnGR ---
5yr EarnGR ---

1yr DivGR ---
3yr DivGR ---
5yr DivGR ---

ROA -65.10%
ROE 108.30%
Picture

​NovoCure Limited
engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) for the treatment of solid tumors. The company markets its proprietary therapy, TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer. It is also involved in conducting clinical trials for the use of TTFields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, and mesothelioma. The company markets its products in the United States, Germany, Switzerland, Japan, and other countries. NovoCure Limited was founded in 2000 and is based in Saint Helier, the Channel Islands.
(Summary) (Company) (Chart)
30 July 2017
Price $20.07
1yr Target $23.00
Analysts 5
Dividend $0.00
Payout Ratio 0.00%

1yr Cap Gain 14.59%
Yield 0.00%
1yr Tot Return 14.59%

P/E ---
PEG ---
Beta ---
EPS (ttm) $-1.33
EPS next yr $-0.26
Forward P/E ---
EPS next 5yr 60.00%
1yr Price Support ---

Market Cap $1.77 Bil
Revenues $104.70 Mil
Earnings $-114.50 Mil
Profit Margin ---

Quick Ratio 6.80
Current Ratio 7.60
Debt/Equity 0.75
1yr RevGR ---
3yr RevGR ---
5yr RevGR ---

1yr EarnGR ---
3yr EarnGR ---
5yr EarnGR ---

1yr DivGR ---
3yr DivGR ---
5yr DivGR ---

ROA -42.10%
ROE -74.30%
Picture

​ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinson's disease psychosis and the Phase II trial for the treatment of schizophrenia, as well as is in Phase II study for the treatment of Alzheimer's disease psychosis. The company has a collaboration with Allergan, Inc. for the development of product candidates related to chronic pain. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
(Summary) (Company) (Chart)
30 July 2017
Price $30.13
1yr Target $44.20
Analysts 10
Dividend $0.00
Payout Ratio 0.00%

1yr Cap Gain 46.69%
Yield 0.00%
1yr Tot Return 46.69%

P/E ---
PEG ---
Beta 3.92
EPS (ttm) $-2.61
EPS next yr $-2.05
Forward P/E ---
EPS next 5yr 28.90%
1yr Price Support ---

Market Cap $3.64 Bil
Revenues $32.60 Mil
Earnings $-309.50 Mil
Profit Margin ---

Quick Ratio 10.70
Current Ratio 10.80
Debt/Equity 0.00
1yr RevGR 28,411.47%
3yr RevGR 145.13%
5yr RevGR 153.00%

1yr EarnGR ---
3yr EarnGR ---
5yr EarnGR ---

1yr DivGR ---
3yr DivGR ---
5yr DivGR ---

ROA -58.40%
ROE -63.10%
Picture
0 Comments

Best Ideas 23 July 2017

7/23/2017

0 Comments

 
Picture
Here's a couple of stock ideas I'm looking at for next week. These are companies I'll consider investing in with any funds that become available in my accounts. They're each showing a nice estimated 1yr ROI, increasing earnings, and pay at least a minimal dividend. I believe each of these has a greater potential return than analysts currently expect. As with all of my investments, I'll start with a small positions and then add to that position over time through dividend reinvestment, the sale of stock options and direct purchases on the open market.
Picture
Momo Inc. operates as a mobile-based social networking platform in the People's Republic of China. The company's platform includes its Momo mobile application and various related features, functionalities, tools, and services that are provided to users, customers, and platform partners. It offers Momo mobile application that enables users to establish and expand their social relationships based on locations and interests; and Hani, a live video application. The company also offers games, which are designed with various themes, cultural characteristics, and features to appeal to various segments of the game player community; paid emoticons, and mobile marketing services; and live video, value-added, and other services. The company was formerly known as Momo Technology Company Limited and changed its name to Momo Inc. Momo Inc. was founded in 2011 and is headquartered in Beijing, the People's Republic of China.
(Summary) (Company) (Chart)
23 July 2017
Price $42.17
1yr Target $48.56
Analysts 13
Dividend $0.00
Payout Ratio ---

1yr Cap Gain 15.15%
Yield 0.00%
1yr Tot Return 15.15%

P/E 39.49
PEG 0.79
Beta ---
EPS (ttm) $1.07
EPS next yr $2.21
Forward P/E 19.10
EPS next 5yr 49.90%
1yr Price Support $110.27

Market Cap $8.08 Bil
Revenues $767.40 Mil
Earnings $219.40 Mil
Profit Margin 28.59%

Quick Ratio 5.60
Current Ratio 5.60
Debt/Equity ​0.00
1yr RevGR %
3yr RevGR %
5yr RevGR %

1yr EarnGR %
3yr EarnGR %
5yr EarnGR %

1yr DivGR %
3yr DivGR %
5yr DivGR %

ROA 30.20%
ROE 36.40%
Picture

​Activision Blizzard, Inc.
develops and publishes games for video game consoles, personal computers (PC), mobile devices, and online social platforms. The company operates through three segments: Activision Publishing, Inc., Blizzard Entertainment, Inc., and King Digital Entertainment. The company develops, publishes, and sells interactive software products and entertainment content through retail channels or digital downloads; and downloadable content. It also publishes subscription-based massive multiplayer online role-playing games; and strategy and role-playing games. In addition, the company maintains a proprietary online gaming service, Battle.net that facilitates the creation of user generated content, digital distribution, and online social connectivity in its games. Further, it engages in creating original film and television content; and provides warehousing, logistics, and sales distribution services to third-party publishers of interactive entertainment software, as well as manufacturers of interactive entertainment hardware products. The company serves retailers and distributors, including mass-market retailers, consumer electronics stores, discount warehouses, game specialty stores, and consumers through third-party distribution and licensing arrangements in the United States, Australia, Brazil, Canada, China, France, Germany, Ireland, Italy, Japan, Malta, Mexico, the Netherlands, Romania, Singapore, South Korea, Spain, Sweden, Taiwan, and the United Kingdom. Activision Blizzard, Inc. was incorporated in 1979 and is headquartered in Santa Monica, California.
(Summary) (Company) (Chart)
23 July 2017
Price $60.93
1yr Target $62.75
Analysts 22
Dividend $0.30
Payout Ratio 22.22%

1yr Cap Gain 2.98%
Yield 0.49%
1yr Tot Return 3.47%

P/E 45.03
PEG 2.47
Beta 1.05
EPS (ttm) $1.35
EPS next yr $2.45
Forward P/E 24.92
EPS next 5yr 18.22%
1yr Price Support $44.63

Market Cap $45.73 Bil
Revenues $6.88 Bil
Earnings $1.03 Bil
Profit Margin 14.97%

Quick Ratio 1.90
Current Ratio 1.90
Debt/Equity 
​0.00
1yr RevGR %
3yr RevGR %
5yr RevGR %

1yr EarnGR %
3yr EarnGR %
5yr EarnGR %

1yr DivGR %
3yr DivGR %
5yr DivGR %

ROA ---
ROE ---
Picture
Picture
0 Comments

Best Ideas 9/16 July 2017

7/16/2017

1 Comment

 
Picture
The markets have been rotating through the various sectors as it tries to decide which sector will be the favorite this week. This is freaking out a lot of long term investors as traders jump from one industry to another. The hottest stocks lately have been in the technology, healthcare and financial services sectors, but even those sectors have seen their share of laggards. Be assured that healthcare's part of the economy will continue to grow as the Baby Boomers continue to age and technology companies are accelerating their penetration throughout the economy. So my best ideas this week will continue to be in those two sectors. ​
Picture
Adobe Systems Incorporated operates as a diversified software company worldwide. Its Digital Media segment provides tools and solutions that enable individuals, small and medium businesses, and enterprises to create, publish, promote, and monetize their digital content. This segment's flagship product is Creative Cloud, a subscription service that allows customers to download and install the latest versions of its creative products. This segment serves traditional content creators, Web application developers, and digital media professionals, as well as their management in marketing departments and agencies, companies, and publishers. The company's Digital Marketing segment offers solutions for how digital advertising and marketing are created, managed, executed, measured, and optimized. This segment provides analytics, social marketing, targeting, advertising and media optimization, digital experience management, cross-channel campaign management, and audience management solutions, as well as video delivery and monetization to digital marketers, advertisers, publishers, merchandisers, Web analysts, chief marketing officers, chief information officers, and chief revenue officers. Its Print and Publishing segment offers products and services, such as eLearning solutions, technical document publishing, Web application development, and high-end printing, as well as publishing needs of technical and business, and original equipment manufacturers (OEMs) printing businesses. The company markets and licenses its products and services directly to enterprise customers through its sales force, as well as to end-users through app stores and through its Website at adobe.com. It also distributes products and services through a network of distributors, value-added resellers, systems integrators, independent software vendors, retailers, and OEMs. The company was founded in 1982 and is headquartered in San Jose, California.
(Summary) (Company) (Chart)
9 July 2017
Price $142.22
1yr Target $158.94
Analysts 26
Dividend $0.00
Payout Ratio ---

1yr Cap Gain 11.75%
Yield 0.00%
1yr Tot Return 11.75%

P/E 49.42
PEG 1.80
Beta 1.00


EPS (ttm) $2.88
EPS next yr $5.09
Forward P/E 27.95
EPS next 5yr 27.40%
1yr Price Support $139.46

Market Cap $70.31 Bil
Revenues $6.53 Bil
Earnings $1.44 Bil
Profit Margin 22.05%

Quick Ratio 2.00
Current Ratio 2.00
Debt/Equity 0.24


1yr RevGR 22.08%
3yr RevGR 12.88%
5yr RevGR 38.85%

1yr EarnGR 87.09%
3yr EarnGR 59.84%
5yr EarnGR 7.44%

1yr DivGR ---
3yr DivGR ---
5yr DivGR ---

ROA 11.20%
ROE 19.20%


Applied Materials, Inc. provides manufacturing equipment, services, and software to the semiconductor, display, and related industries worldwide. It operates through three segments: Semiconductor Systems, Applied Global Services, and Display and Adjacent Markets. The Semiconductor Systems segment develops, manufactures, and sells a range of manufacturing equipment used to fabricate semiconductor chips or integrated circuits. It offers products and technologies for transistor and interconnect fabrication, including epitaxy, ion implantation, oxidation and nitridation, rapid thermal processing, chemical vapor deposition, physical vapor deposition, chemical mechanical planarization, and electrochemical deposition; patterning, selective removal, and packaging products and systems that enable the transfer of patterns onto device structures; and metrology, inspection, and review systems for front- and back-end-of-line applications. The Applied Global Services segment provides integrated solutions to optimize equipment and fab performance and productivity, including spares, upgrades, services, remanufactured earlier generation equipment, and factory automation software for semiconductor, display, and other products. The Display and Adjacent Markets segment offers products for manufacturing liquid crystal displays, organic light-emitting diodes, and other display technologies for TVs, personal computers, tablets, smart phones, and other consumer-oriented devices, as well as equipment for flexible substrates. The company serves manufacturers of semiconductor wafers and chips, liquid crystal and other displays, and other electronic devices. Applied Materials, Inc. was founded in 1967 and is headquartered in Santa Clara, California.
​(Summary) (Company) (Chart)
9 July 2017
Price $43.54
1yr Target $50.30
Analysts 22
Dividend $0.40
Payout Ratio 16.46%

1yr Cap Gain 15.52%
Yield 0.91%
1yr Tot Return 16.43%

P/E 17.95
PEG 0.69
Beta 1.79
EPS (ttm) $2.43
EPS next yr $3.23
Forward P/E 13.48
EPS next 5yr 26.19%
1yr Price Support $84.59

Market Cap $46.94 Bil
Revenues $12.94 Bil
Earnings $2.64 Bil
Profit Margin 20.40%

Quick Ratio 2.30
Current Ratio 2.90
Debt/Equity 0.67


1yr RevGR 12.07%
3yr RevGR 12.82%
5yr RevGR 0.57%

1yr EarnGR 37.50%
3yr EarnGR 92.99%
5yr EarnGR 1.21%

1yr DivGR 0.00%
3yr DivGR 0.83%
5yr DivGR 5.23%

ROA 17.10%
ROE 35.30%


Universal Display Corporation engages in the research, development, and commercialization of organic light emitting diode (OLED) technologies and materials for use in flat panel displays and solid-state lighting applications. It owns, exclusively licenses, or has the sole right to sublicense approximately 4,200 patents issued and pending worldwide. The company licenses and supplies its proprietary UniversalPHOLED materials to display manufacturers and others. It is also involved in the research, development, and commercialization of other OLED device and manufacturing technologies, including FOLED that are flexible OLEDs for the fabrication of OLEDs on flexible substrates; encapsulation technology for the packaging of flexible OLEDs and other thin-film devices, as well as for use as a barrier film for plastic substrates; UniversalP2OLED, which are printable phosphorescent OLEDs; OVJP, an organic vapor jet printing technology; OVPD, an organic vapor phase deposition for manufacturing a small molecule OLED; and TOLED, which are transparent OLEDs for the fabrication of OLEDs that have transparent cathodes. In addition, the company provides technology development and support services, including government contract work and support provided to third parties for the commercialization of their OLED products. It has strategic relationships with Samsung Display Co., Ltd.; LG Display Co., Ltd.; AU Optronics Corporation; BOE Technology Group Co., Ltd.; Innolux Corporation; Kaneka Corporation; Konica Minolta Holdings Inc.; Lumiotec, Inc.; LG Chem, Ltd.; NEC Lighting, Ltd.; Osram GmbH; Pioneer Corporation; Sony; Sumitomo Chemical Co., Ltd.; and Tianma Micro-electronics Co., Ltd. The company was founded in 1985 and is headquartered in Ewing, New Jersey.
(Summary) (Company) (Chart)
9 July 2017
Price $111.15
1yr Target $125.40
Analysts 5
Dividend $0.12
Payout Ratio 9.75%

1yr Cap Gain 12.82%
Yield 0.10%
1yr Tot Return 12.92%

P/E 90.66
PEG 4.12
Beta 1.01
EPS (ttm) $1.23
EPS next yr $2.55
Forward P/E 43.66
EPS next 5yr 38.29%
1yr Price Support $97.63

Market Cap $5.29 Bil
Revenues $224.70 Mil
Earnings $56.50 Mil
Profit Margin 25.14%

Quick Ratio 11.00
Current Ratio 11.50
Debt/Equity 0.00
1yr RevGR 4.09%
3yr RevGR 10.58%
5yr RevGR 26.54%

1yr EarnGR 229.03%
3yr EarnGR -13.63%
5yr EarnGR 70.88%

1yr DivGR ---
3yr DivGR ---
5yr DivGR ---

ROA 9.20%
ROE 10.80%


BioTelemetry, Inc. provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. The company operates in three segments: Healthcare, Research, and Technology. The Healthcare segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. It offers Mobile Cardiac Outpatient Telemetry and External Cardiac Ambulatory Telemetry services, which incorporates a lightweight patient-worn sensor attached to electrodes that capture two-channel electrocardiography (ECG) data, measuring electrical activity of the heart, on a compact wireless handheld monitor; event monitoring services to prescribe wireless event monitors, digital loop event monitors, memory loop event monitors, and non-loop event monitors; and a Holter and extended-wear Holter monitors to cardiologists and electrophysiologists. The Research Services segment provides cardiac monitoring, imaging, scientific consulting, and data management services for drug, medical treatment, and device trials to pharmaceutical companies and contract research organizations. Its centralized services include ECG, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, and expert reporting and statistical analysis. This segment also offers services in the cardiovascular, oncology, musculoskeletal, and neurologic therapeutic areas; and support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The Technology segment focuses on the manufacture, engineering, and development of non-invasive cardiac monitors for healthcare companies, clinics, and hospitals worldwide. This segment offers various devices, including cardiac event monitors, digital Holter monitors, and mobile cardiac telemetry monitors. BioTelemetry, Inc. is headquartered in Malvern, Pennsylvania.
(Summary) (Company) (Chart)
9 July 2017
Price $32.85
1yr Target $38.00
Analysts 4
Dividend $0.00
Payout Ratio ---

1yr Cap Gain 15.67%
Yield 0.00%
1yr Tot Return 15.67%

P/E 21.15
PEG 0.97
Beta 0.76
EPS (ttm) $1.55
EPS next yr $1.16
Forward P/E 28.44
EPS next 5yr 21.90%
1yr Price Support $25.04

Market Cap $933.89 Mil
Revenues $215.60 Mil
Earnings $49.70 Mil
Profit Margin 23.05%

Quick Ratio 1.80
Current Ratio 1.90
Debt/Equity 0.18
1yr RevGR 16.70%
3yr RevGR ---
5yr RevGR ----

1yr EarnGR 573.07%
3yr EarnGR ---
5yr EarnGR ----

1yr DivGR ---
3yr DivGR ---
5yr DivGR ---

ROA 27.40%
ROE 42.70%


1 Comment

Best Ideas 2 July 2017

7/2/2017

0 Comments

 
Picture
As the markets rotate and cycle stocks into and out of the technology, healthcare and financial sectors, a lot of good names are being trashed with the bad. Healthcare's part of the economy will continue to grow as the Baby Boomers continue to age, and Technology isn't going anywhere but is instead accelerating its penetration into the economy. So my best ideas this week will continue to be in those two sectors. 
Picture
CryoLife, Inc. manufactures and distributes medical devices worldwide. It also processes and distributes implantable human tissues for use in cardiac and vascular surgeries. The company operates in two segments, Medical Devices and Preservation Services. It offers surgical sealants and hemostats, including BioGlue Surgical Adhesive, an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; BioFoam Surgical Matrix, which is used as an adjunct in sealing abdominal parenchymal tissues, as well as an adjunct for hemostasis in cardiovascular surgery; and PerClot, an absorbable powdered hemostat for use in surgical procedures, including cardiac, vascular, orthopedic, neurological, gynecological, ENT, and trauma surgeries. The company also provides cardiac laser therapy products, which include laser console system and single-use, as well as fiber-optic hand-pieces for the treatment of coronary artery disease in patients with severe angina; and On-X heart valves for aortic and mitral indications. In addition, it distributes ProCol vascular bioprosthesis, a biological graft that provides vascular access for end-stage renal disease in hemodialysis patients; and PhotoFix, a bovine pericardial patch for use in cardiac and vascular repairing activities. Further, it distributes CryoValve SG pulmonary heart valves and CryoPatch SG pulmonary cardiac patch tissues that are processed using its proprietary SynerGraft technology; and vascular preservation services, such as CryoVein and CryoArtery tissues to treat various vascular reconstructions, such as peripheral bypass, hemodialysis access, and aortic infections. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.
(Summary) (Company) (Chart)
2 July 2017
Price $19.95
1yr Target $23.00
Analysts 5
Dividend $0.12
Payout Ratio 38.70%

1yr Cap Gain 15.28%
Yield 0.60%
1yr Tot Return 15.88%

P/E 64.77
PEG 2.16
Beta 1.02
EPS (ttm) $0.31
EPS next yr $0.50
Forward P/E 39.90
EPS next 5yr 30.00%
1yr Price Support $15.00

Market Cap $666.93 Mil
Revenues $182.40 Mil
Earnings $10.30 Mil
Profit Margin 5.64%

Quick Ratio 4.40
Current Ratio 5.30
Debt/Equity 0.33
1yr RevGR 23.63%
3yr RevGR 8.52%
5yr RevGR 8.56%

1yr EarnGR 128.57%
3yr EarnGR -17.35%
5yr EarnGR 4.24%

1yr DivGR 0.00%
3yr DivGR 3.53%
5yr DivGR ---

ROA 3.30%
ROE 5.00%
Picture
CryoLife Monthly Chart
Picture
CryoLife Dividend History

​Apple Inc.
 designs, manufactures, and markets mobile communication and media devices, personal computers, and portable digital music players to consumers, small and mid-sized businesses, and education, enterprise, and government customers worldwide. The company also sells related software, services, accessories, networking solutions, and third-party digital content and applications. It offers iPhone, a line of smartphones; iPad, a line of multi-purpose tablets; and Mac, a line of desktop and portable personal computers. The company also provides iLife, a consumer-oriented digital lifestyle software application suite; iWork, an integrated productivity suite that helps users create, present, and publish documents, presentations, and spreadsheets; and other application software, such as Final Cut Pro, Logic Pro X, and FileMaker Pro. In addition, it offers Apple TV that connects to consumers' TV and enables them to access digital content directly for streaming high definition video, playing music and games, and viewing photos; Apple Watch, a personal electronic device; and iPod, a line of portable digital music and media players. Further, the company sells Apple-branded and third-party Mac-compatible, and iOS-compatible accessories, such as headphones, displays, storage devices, Beats products, and other connectivity and computing products and supplies. Additionally, it offers iCloud, a cloud service; AppleCare that offers support options for its customers; and Apple Pay, a mobile payment service. The company sells and delivers digital content and applications through the iTunes Store, App Store, Mac App Store, TV App Store, iBooks Store, and Apple Music. It also sells its products through its retail and online stores, and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers, and value-added resellers. Apple Inc. was founded in 1977 and is headquartered in Cupertino, California.
(Summary) (Company) (Chart)
25 June 2017
Price $146.28
1yr Target $157.58
Analysts 42
Dividend $2.52
Payout Ratio 29.47%

1yr Cap Gain 7.72%
Yield 1.72%
1yr Tot Return 9.44%

P/E 17.11
PEG 1.55
Beta 1.29
EPS (ttm) $8.55
EPS next yr $10.53
Forward P/E 13.89
EPS next 5yr 11.07%
1yr Price Support $116.56

Market Cap $773.51 Bil
Revenues $220.46 Bil
Earnings $45.73 Bil
Profit Margin 20.74%

Quick Ratio 1.40
Current Ratio 1.40
Debt/Equity 0.73
1yr RevGR -7.74%
3yr RevGR 7.97%
5yr RevGR 14.77%

1yr EarnGR -9.87%
3yr EarnGR 13.37%
5yr EarnGR 16.01%

1yr DivGR 9.85%
3yr DivGR 9.66%
5yr DivGR ---

ROA 14.10%
ROE 35.10%
Picture
Apple Monthly Chart
Picture
Apple Dividend History
0 Comments
    Picture
    Dennis McCain

    Author

    I am an Individual Investor with specific interest in long term growth and then enhancing my returns with income from dividends and derivatives. I don't recommend stocks to anyone (it's a good way to lose friends) and no one reading this should misinterpret my blog as a recommendation for any type of investment. I am writing this solely for myself and my kids.

    Picture
    Top 100 Blogs for Dividend Investors

    Archives

    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014

    DISCLAIMER
     I am not a licensed investment adviser, and I am not providing investment advise for you on this site. Please consult with an investment professional before you invest your money. Any opinion expressed here should not be treated as investment advice. I am not liable for any losses suffered by any party because of data or information published on this blog. Past performance is not a guarantee of future performance. Unless your investments are FDIC insured, they may decline in value.

    Categories

    All

    RSS Feed

Powered by Create your own unique website with customizable templates.